Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines
about
Efficient chemoenzymatic synthesis of biotinylated human serum albumin-sialoglycoside conjugates containing O-acetylated sialic acids.Advances in the biology and chemistry of sialic acids.Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine.Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriersSynthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4'-deoxy-4'-fluoro-Thomsen-Friedenreich epitope.Bioorthogonal chemical reporter methodology for visualization, isolation and analysis of glycoconjugatesDeciphering glycan linkages involved in Jurkat cell interactions with gold-coated nanofibers via sugar-displayed thiols.Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine CandidatesCarbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouseA novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell.Sialic acid metabolism and sialyltransferases: natural functions and applications.Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.Synthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteinsCowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines.Metabolic glycoengineering: sialic acid and beyondCombining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.Recent development in carbohydrate-based cancer vaccines.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.Efficient chemoenzymatic synthesis of sialyl Tn-antigens and derivatives.Synthetic and Immunological Studies of sTn Derivatives Carrying 5-N-(p-Substituted Phenylacetyl)Sialic Acid for the Development of Effective Cancer Vaccines.Chemical diversification of sialic acid glycosides by stereospecific, chemoselective deamination.One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.
P2860
Q33291127-F60C0E60-42B7-4C12-8775-94EA6BCB21DEQ33519629-023DB879-F974-4881-8F6A-1A90785D00B6Q33709802-DE26023E-DFEA-43A9-B3B8-B22EDE728A22Q33819711-5BFB92D3-5C54-4D1D-9DEF-19DA4D754EA6Q35030845-9AE28150-78D6-4AE6-99F5-F70E27A4C03CQ35123584-98AFAA03-36F8-421F-B24D-A1B03631FAB9Q35165014-87E5460A-01FA-4975-A695-A8823234F8FEQ35212122-426B696E-BEBC-411C-9DF2-7EE82B8FF4B7Q35685656-2D53D8BD-BBD2-43E2-B0BC-A00A0953AE19Q35741638-E4320D07-2DFB-4D5D-B796-0572F81440A2Q36166263-CDE62844-224D-4E6E-AAA4-C51312CFF5DAQ36501918-5DFEEBC3-1122-4408-990C-5C4D25A960EAQ36557966-B44E5C60-F9AD-44C6-927B-88042771DB11Q36850638-A259603C-E782-417A-9E16-FDD526DE7D5CQ37120643-8AA16FC2-BC86-4BDA-9672-D66BE9AE6751Q37312793-3866DB78-4CBC-4285-B2A8-7B7AF7444C52Q37405391-B43A005B-FAAB-46FD-B0C0-49D3D283155AQ37418500-5164D5BC-8A07-4D41-8D41-4ECE4A01F73DQ37455940-C1F0F7EC-4D04-46BD-8E76-7FACF5AFB519Q37993590-EB7E6F65-630F-447C-AF42-1CB5F9627927Q38016342-9AF33DA2-C517-4802-ADF3-036D29FE3F87Q38828915-6782DE0C-4F62-4021-9DE0-46A828662326Q41809862-90B867C2-57EE-448C-844E-40D0882CB544Q42789515-74D43CCE-C81A-47AE-BCC1-BA0FA246C8AEQ43076252-6BEACE4F-231B-4640-AC4F-7435A6B98584
P2860
Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Improving the antigenicity of ...... glycoconjugate cancer vaccines
@en
type
label
Improving the antigenicity of ...... glycoconjugate cancer vaccines
@en
prefLabel
Improving the antigenicity of ...... glycoconjugate cancer vaccines
@en
P2860
P356
P1476
Improving the antigenicity of ...... glycoconjugate cancer vaccines
@en
P2093
P2860
P304
P356
10.1021/BC060103S
P577
2006-11-01T00:00:00Z